Reza Mohebi

1.6k total citations · 1 hit paper
65 papers, 987 citations indexed

About

Reza Mohebi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Reza Mohebi has authored 65 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 21 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Surgery. Recurrent topics in Reza Mohebi's work include Heart Failure Treatment and Management (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cardiovascular Function and Risk Factors (10 papers). Reza Mohebi is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cardiovascular Function and Risk Factors (10 papers). Reza Mohebi collaborates with scholars based in United States, Iran and Netherlands. Reza Mohebi's co-authors include Farzad Hadaegh, Fereidoun Azizi, Maryam Tohidi, Mitra Hasheminia, Davood Khalili, Hanna K. Gaggin, James L. Januzzi, Cian P. McCarthy, James L. Januzzi and Nasrien E. Ibrahim and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Reza Mohebi

60 papers receiving 965 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates

2022 171 citations Reza Mohebi, Chen Chen et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Reza Mohebi

Since Specialization

Citations

This map shows the geographic impact of Reza Mohebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Mohebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Mohebi more than expected).

Fields of papers citing papers by Reza Mohebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Mohebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Mohebi. The network helps show where Reza Mohebi may publish in the future.

Co-authorship network of co-authors of Reza Mohebi

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Mohebi. A scholar is included among the top collaborators of Reza Mohebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Mohebi. Reza Mohebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial 2024 ·Cardiovascular Diabetology ·James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas H. Marwick, W.H. Wilson Tang, Yuxi Liu, Reza Mohebi, (unknown), Faı̈ez Zannad, Riccardo Perfetti	12
2	The role of early-phase trials and real-world evidence in drug development 2024 ·Nature Cardiovascular Research ·Harriette G.C. Van Spall, Arnaud Bastien, Bernard J. Gersh, Barry Greenberg, Reza Mohebi, James K. Min, Karsten M. Strauss, Steffen Thirstrup, Faı̈ez Zannad	3
3	Race-Free Creatinine-Based Estimation of GFR and Projection of CKD to 2060 in the United States 2023 ·Clinical Journal of the American Society of Nephrology ·Reza Mohebi, Josef Coresh, Deidra C. Crews, Michelle M. Estrella, Andrew S. Levey, Yuxi Liu, Kunihiro Matsushita, Michael G. Shlipak, James L. Januzzi	0
4	Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points 2023 ·Clinical Journal of the American Society of Nephrology ·Reza Mohebi, Yuxi Liu, Michael K. Hansen, Yshai Yavin, Naveed Sattar, Carol A. Pollock, Javed Butler, Meg Jardine, Serge Masson, Hiddo J.L. Heerspink, James L. Januzzi	5
5	Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort 2023 ·Journal of the American College of Cardiology ·Reza Mohebi, Dongyu Wang, Emily S. Lau, (unknown), Norrina B. Allen, Bruce M. Psaty, Emelia J. Benjamin, Daniel Levy, Thomas J. Wang, Sanjiv J. Shah, John S. Gottdiener, James L. Januzzi, Jennifer E. Ho	14
6	Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction 2023 ·Journal of the American College of Cardiology ·Cian P. McCarthy, Seán Murphy, (unknown), Paula Rambarat, (unknown), Yuxi Liu, Reza Mohebi, A.P. Levin, Avanthi Raghavan, (unknown), Campbell Rogers, Jason H. Wasfy, Ron Blankstein, Brian Ghoshhajra, Sandeep Hedgire, James L. Januzzi	5
7	Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database 2023 ·International Journal of Cardiology ·Reza Mohebi, Yuxi Liu, Sean Murphy, Hanna K. Gaggin, James L. Januzzi	1
8	A Biomarker‐Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy 2022 ·Journal of the American Heart Association ·Reza Mohebi, Roland van Kimmenade, Cian P. McCarthy, Hanna K. Gaggin, Roxana Mehran, George Dangas, James L. Januzzi	7
9	Performance of a multi-biomarker panel for prediction of cardiovascular event in patients with chronic kidney disease 2022 ·International Journal of Cardiology ·Reza Mohebi, Roland van Kimmenade, Cian P. McCarthy, Craig A. Magaret, (unknown), (unknown), Hanna K. Gaggin, James L. Januzzi	5
10	Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates breakdown → 2022 ·Journal of the American College of Cardiology ·Reza Mohebi, Chen Chen, Nasrien E. Ibrahim, Cian P. McCarthy, Hanna K. Gaggin, Daniel E. Singer, Emily P. Hyle, Jason H. Wasfy, James L. Januzzi	171
11	Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction 2022 ·Journal of the American College of Cardiology ·Reza Mohebi, Yuxi Liu, Ileana L. Piña, Margaret F. Prescott, Javed Butler, G. Michael Felker, Jonathan H. Ward, Scott D. Solomon, James L. Januzzi	19
12	Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction 2021 ·Circulation Cardiovascular Interventions ·Björn Redfors, Reza Mohebi, Gennaro Giustino, Shmuel Chen, Harry P. Selker, Hölger Thiele, Manesh R. Patel, James E. Udelson, E. Magnus Ohman, Ingo Eitel, Christopher B. Granger, Akiko Maehara, Ziad A. Ali, Ori Ben‐Yehuda, Gregg W. Stone	34
13	PRETREATMENT WITH SGLT2 INHIBITORS AMELIORATES CONTRAST-INDUCED NEPHROPATHY 2020 ·Journal of the American College of Cardiology ·Carlos G. Santos‐Gallego, (unknown), Juan Antonio Requena-Ibáñez, (unknown), Reza Mohebi, Vivian M. Abascal, Pedro Moreno, Juan J. Badimón	6
14	Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study 2015 ·Journal of Renal Nutrition ·Reza Mohebi, (unknown), Maryam Tohidi, Fereidoun Azizi, Farzad Hadaegh	19
15	Association of leptin gene (rs 7799039) polymorphism and colorectal cancer 2013 ·Bimonthly Journal of Hormozgan University of Medical Sciences ·(unknown), Akbar Safaei, (unknown), Mohsen Vahedi, Reza Mohebi, (unknown), (unknown), Mohammad Reza Zali	1
16	Association of IGFBP3 Gene (rs2854744) Polymorphism and Colorectal Cancer 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Mohsen Vahedi, Reza Mohebi, (unknown), (unknown), Mohammad Reza Zali	2
17	Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran 2012 ·BMC Neurology ·Noushin Fahimfar, Davood Khalili, Reza Mohebi, Fereidoun Azizi, Farzad Hadaegh	46
18	Incidence of Chronic Kidney Disease and Its Risk Factors, Results of Over 10 Year Follow Up in an Iranian Cohort 2012 ·PLoS ONE ·Maryam Tohidi, Mitra Hasheminia, Reza Mohebi, Davood Khalili, Farhad Hosseinpanah, (unknown), (unknown), Fereidoun Azizi, Farzad Hadaegh	117
19	The analgesic effect of oral administration of Artemisia dracunculus in diabetic rats: a behavioral analysis using formalin test 2010 ·Iranian journal of pharmaceutical research ·Mehrdad Roghani, Tourandokht Baluchnejadmojarad, Zahra Sohrabi, Morteza Sadeghi, (unknown), Reza Mohebi, Nahid Nahavandi	1
20	Single Nucleotide Polymorphisms of DNA Methyltransferase 1 Gene and Gastric Cancer in Iranian Patients: a Case Control Study 2008 ·Iranian Journal of Cancer Prevention ·Fatemeh Khatami, Babak Noorinayer, (unknown), Reza Mohebi, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact